基于文献舒肝解郁胶囊临床应用文本挖掘研究.docVIP

基于文献舒肝解郁胶囊临床应用文本挖掘研究.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
基于文献舒肝解郁胶囊临床应用文本挖掘研究

基于文献舒肝解郁胶囊临床应用文本挖掘研究   [摘要] ?研究主要分析舒肝解郁胶囊的临床应用特点,通过文本挖掘技术检索中文生物医学期刊数据库,搜集关于舒肝解郁胶囊的论文数据,利用基于关键词频数统计的数据分层方法,挖掘数据集中证型、疾病、症状、联用药物等方面的信息。挖掘结果通过一维频次并构建联系图进行展示。通过挖掘共检索出190篇舒肝解郁胶囊相关的论文。分析显示舒肝解郁胶囊的临床使用多与肝郁、气滞等证型类别相关;舒肝解郁胶囊运用的主要疾病包括原发性抑郁发作、脑器质性抑郁障碍、躯体疾病伴发抑郁、功能性消化不良、精神分裂症伴发抑郁等精神科、心身科疾病;舒肝解郁胶囊主治的症状包括情绪低落、精神性焦虑、躯体性焦虑、自主神经功能紊乱等;舒肝解郁胶囊常与帕罗西汀、舍曲林、氟西汀等药物联合使用。研究结果提示舒肝解郁胶囊治疗的证型、疾病等挖掘分析结果与其说明书中基本吻合,潜在治疗证型为心神失养证,潜在治疗疾病为躯体疾病伴发抑郁焦虑共病、原发性抑郁焦虑共病、产后抑郁等。其常见联用药物为帕罗西汀、舍曲林、氟西汀。   [关键词] 文本挖掘; 舒肝解郁胶囊; 中医药; 治疗   Exploring the clinical characters of Shugan Jieyu capsule through text mining   PU Zhengping1,2, XIA Jiangming2, XIE Wei3, HE Jincai1*   (1. Graduate School, Wenzhou Medical University, Wenzhou 325035, China;   2. Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing 314500, China;   3. Department of Automation, Tsinghua University, Beijing 100084, China)   [Abstract] The study was main to explore the clinical characters of Shugan Jieyu capsule through text mining. The data sets of Shugan Jieyu capsule were downloaded from CMCC database by the method of literature retrieved from May 2009 to Jan 2016. Rules of Chinese medical patterns, diseases, symptoms and combination treatment were mined out by data slicing algorithm, and they were demonstrated in frequency tables and two dimension based network. Then totally 190 literature were recruited. The outcomess suggested that SC was most frequently correlated with liver Qi stagnation. Primary depression, depression due to brain disease, concomitant depression followed by physical diseases, concomitant depression followed by schizophrenia and functional dyspepsia were main diseases treated by Shugan Jieyu capsule. Symptoms like low mood, psychic anxiety, somatic anxiety and dysfunction of automatic nerve were mainy relieved bv Shugan Jieyu capsule.For combination treatment. Shugan Jieyu capsule was most commonly used with paroxetine, sertraline and fluoxetine. The research suggested that syndrome types and mining results of Shugan

文档评论(0)

bokegood + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档